Studies with purified nitric oxide synthase from rat cerebellum have confirmed previous reports that product formation is enhanced by tetrahydrobiopterin [H4B; 6-(L-erythro-1,2-dihydroxypropyl)- 5,6,7,8-tetrahydropterin]. The effect of the natural isomer, (6R)-H4B, is observed at extremely low (<0.1 ,uM) concentrations and is remarkably selective. At these concentrations, only the diastereoisomer (6S)-H4B, the structural isomer 7-(L-eiythro-1,2-dihydroxypropyl) -5,6,7,8-tetrahydropterin, and 7,8-dihydrobiopterin showed detectable effects. Our observations are inconsistent with a stoichiometric role for H4B in the oxygenation of arginine [e.g., Stuehr, D. J., Kwon, N. S., Nathan, C. F.,
added H4B; enhanced product formation with H4B is observed only as incubation progresses. The effect of H4B is catalytic, with each mole of added H4B supporting the formation of >15 mol of product. Recycling of H4B was excluded by direct measurement during nitric oxide synthesis and by the demonstration that nitric oxide synthase is not inhibited by methotrexate. These combined results exclude R4B as a stoichiometric reactant and suggest that H4B enhances product formation by protecting enzyme activity against progressive loss. Preliminary studies indicate that the decreased activity in the absence of added H4B does not depend on catalytic turnover of the enzyme. The role of H4B may be allosteric or it may function to maintain some group(s) on the enzyme in a reduced state required for activity.
Nitric oxide synthase (NOS) catalyzes the oxygenation of arginine in the presence of NADPH to form nitric oxide, citrulline, and NADP'. The enzyme is of great interest because nitric oxide appears to participate in a variety of physiological processes. In addition to its classic role as the endothelium-derived relaxing factor in mediating vasodilation (1-3), nitric oxide has been implicated in regulating macrophage antitumor and antimicrobial activity, platelet adhesion, and cerebellar signaling (4) . Nitric oxide stimulates guanylate cyclase, yielding increased production of cyclic GMP that is proposed to mediate cerebellar signaling and possibly other physiological effects of nitric oxide (4) . NOS has been reported in a variety of mammalian tissues (4) .
Differences in cofactor, substrate, and inhibitor specificities suggest that NOS may exist in at least three distinct forms (4) (5) (6) .
Tetrahydrobiopterin [H4B; 6-(L-erythro-1,2-dihydroxypropyl)-5,6,7,8-tetrahydropterin] causes a marked and specific stimulation of macrophage NOS (7, 8) . The original studies of Bredt and Snyder (9) of purified brain (cerebellar) NOS did not include the effects of H4B. However, recent studies show that activity of cerebellar NOS is also increased by H4B (10, 11) . The biochemical basis for this effect is poorly understood. Studies of the macrophage enzyme (7, 12, 13) have been interpreted as showing that H4B participates stoichiometrically in the reaction; i.e., it provides reducing equivalents required for the overall oxygenation of arginine to nitric oxide and citrulline.
The present studies on purified NOS from rat cerebellum show that this is not the case for the brain enzyme. H4B is shown to preserve NOS activity in vitro by preventing the progressive loss of activity that otherwise proceeds in the absence of this factor. The effect is observed at extremely Purification of NOS. Except for the modifications noted, NOS was purified by the method of Bredt and Snyder (9) . Frozen male Sprague-Dawley rat cerebella from Bioproducts for Science (Indianapolis) were used. The crude supernatant from frozen cerebella gave the same level of NOS activity as fresh cerebella. The number of rat cerebella was increased 4-fold to 72, and the volume of the DEAE-Sephacel (Pharmacia) column was increased from 20 ml to 30 ml (2.5-cm internal diameter). The active fractions obtained from DEAE-Sephacel chromatography were applied to a column of adenosine 2',5'-bisphosphate (2',5'-ADP)-Sepharose 4B and eluted with a buffer containing 10 mM NADPH (9) . This eluate was concentrated first in a Centricell of 30,000 nominal molecular weight limit (Polysciences), and then in a Centricon-30 (Amicon) concentrator to a final volume of -100 ,u. Prior to use, both concentrators were preblocked with NOS from earlier purifications, to minimize loss of protein by adsorption, and then washed with 10 mM Tris HCl, pH 7.4/1 mM EDTA/20%o (vol/vol) glycerol. The concentrated enzyme was then diluted with 2 ml of this buffer and again concentrated to -100 pA. This step was repeated twice to yield an =80-fold concentrated preparation that was essentially free of the NADPH and mercaptoethanol originally present in the eluate. All procedures were carried out at 40C, unless stated otherwise, and completed within 15 hr of the initial homogenization of cerebella. Protein was determined by the method of Bradford (18) (11) and 960 nmol/min per mg by Bredt and Snyder (9) . Decreases in specific activity of as much as 75% were sometimes observed during the concentration-washing step. One possible explanation for this variation and loss in specific activity is the extreme instability at 40C of dilute solutions of the purified enzyme observed by us and by other workers (9, 11, 19 of the maximum stimulation observed with (6R)-H4B. Fig. 1 illustrates a more detailed study of the time course of activity in the presence or absence of H4B. The reaction is independent of added H4B over the first few minutes, during which time the enzyme turns over at maximal rate -18 times (0.018 ,AM citrulline/0.001 ,uM enzyme) in the absence of added H4B. Rates in the absence of H4B progressively decline after 2 min, while that in the presence of H4B remains relatively constant. The net effect is that the apparent stimulation in rate by H4B becomes progressively greater with incubation time.
The ability of the reaction to proceed optimally in the absence of H4B during early incubation times suggests that H4B is not reacting stoichiometrically in nitric oxide synthesis but rather acting to prevent progressive loss of enzyme activity with increasing incubation time. Further evidence for this proposal is provided in Fig. 2 , which illustrates the effects of H4B concentration on total product formation (upper curve) and H4B-dependent product formation (lower curve). H4B is effective at very low concentrations, with half-maximum stimulation being obtained at only 0.02 ,uM H4B. Each mole of added H4B can support the formation of many moles of product (Fig. 2 Inset) . For example, extrapolation of the curve to lower concentrations of H4B indicates that 1 mol of H4B can catalyze the formation of >15 mol of product.
These combined results do not exclude the possibility that H4B is a stoichiometric reactant in nitric oxide synthesis if the proposed product of such a reaction, H2B, is recycled to H4B. Studies with the aromatic amino acid hydroxylases show that the dihydropterin product formed initially is the quinonoid form of H2B (20 (10 ,uM) of NADPH in the assay. The studies described below were conducted to provide direct evidence against recycling of H4B either chemically or enzymically. Methods). NADPH is the preferred substrate for DHFR (26) and methylenetetrahydrofolate reductase (22) , whereas NADH is preferred for DHPR (14) . Bovine liver has been MM and MTX at 100 AM.
reported to contain two distinct species of DHPR, one of which resembles the majority of mammalian DHPR enzymes in being relatively specific for NADH, while the other is specific for NADPH (27) . Positive control experiments established that product formation was linear with DHPR to at least 75 pmol of tyrosine per 30 min, and for DHFR to at least 200 pmol of tyrosine per 30 min. In the absence of enzyme, the amount of tyrosine formed (c2.5 pmol) was at the limit of detection of the assay.
The relative ability of NOS to catalyze citrulline synthesis and H4B recycling (tyrosine synthesis) was compared in two experiments ( Table 2 ). In the first, addition of H4B (7.5 pmol) resulted in an increased synthesis of 146 pmol of citrulline, most of which (146 -7.5 = 138.5 pmol) would have to be derived from recycling if H4B were a stoichiometric component of the reaction. No H4B recycling was detected above that expected to be formed from the 2.5 pmol of added H4B.
Any H4B recycled would therefore have been <2% {[2.5/(146 -7.5)] x 100} of that required for stoichiometric reaction of H4B. In the second experiment, a comparable value of 5% {[2.5/(57 -7.5)] x 100} was obtained when H4B recycling was assayed under conditions A and C instead of condition B.
Further evidence against recycling ofH4B was provided by studies of the effects of methotrexate (MTX) on NOS activity. MTX is an extraordinarily potent inhibitor of DHFR, with a K, in the nanomolar range (28) . MTX at much higher concentrations causes comparable inhibition of DHPR (14) and methylenetetrahydrofolate reductase (29, 30) . Separate experiments (data not shown) confirmed that 100 MM MTX caused =70%o inhibition of DHPR when the enzyme was assayed by the recycling assay with either NADH or NADPH, in good agreement with the reported K1 value of 38 ,uM (14) . Table 3 Preliminary studies suggest that loss of activity in the absence of H4B is not dependent on catalytic turnover of the enzyme. In these studies, NOS was preincubated in the presence or absence of H4B under conditions either allowing or precluding catalytic turnover. After preincubation, any omitted component was restored to the reaction mixture and NOS activity was determined. The results of Table 4 show comparable NOS activity by omission of H4B from the preincubation even without enzyme turnover.
DISCUSSION
The absolute requirements observed for NADPH, Ca2+, and calmodulin are in agreement with previous studies on the cerebellar enzyme (9, 10) . Further, NADH will not substitute for NADPH. FAD and GSH were found to be necessary for maximum activity in a NOS system from macrophages (8) . The enhancement of product formation by H4B addition showed a very high affinity (Fig. 2) and selectivity (Table 1) for this factor. Most remarkable is the very high structural and stereo selectivity for the pterin. Even the closely related structural isomer (7)-H4B, the diastereoisomer (6S)-H4B, and 6-methyl-5,6,7,8-tetrahydropterin were significantly less active than (6R)-H4B. A marked selectivity for H4B has also been reported for macrophage NOS (12) . The small but significant stimulation by H2B (Table 1) and its combined effect with H4B (Table 3 ) has a special significance, which is discussed below.
A major finding of this work is that H4B is not a stoichiometric component in the reaction catalyzed by NOS from rat cerebellum. Rather, H4B plays a role in the prevention of progressive loss of enzyme activity. This conclusion is based on the following findings: (i) The initial rate of NOS is independent of H4B. An effect of this factor is revealed only as incubation progresses (Fig. 1). (it) The catalytic role ofH4B was demonstrated by the finding that at low concentrations each mole of added H4B can support the formation of at least 15 mol of product (Fig. 2) (Table 3) .
Our studies on the mechanism of action of H4B are at a preliminary stage. Many of the effects of H4B on NOS resemble, superficially at least, those of ascorbate in the prolyl hydroxylase reaction. In that reaction, ascorbate is not a stoichiometric reactant and is required only after 15-30 reaction cycles, after which the reaction rate declines, probably due to oxidation of enzyme-bound iron in the catalytic process (32, 33) . Catalytic turnover of enzyme is a necessary feature of this model. The finding that inactivation of NOS in the absence of H4B proceeds without catalytic turnover (Table 4) argues against H4B playing a role with NOS that is similar to that of ascorbate in the prolyl hydroxylase system. Two viable models remain for the role of H4B. In the first, H4B maintains some group(s) on the enzyme in a reduced state required for activity. A precedent for this model is the role of H4B in maintaining PAH in the reduced form required for enzyme activity; this requirement for H4B is observed in the absence of catalytic turnover of enzyme (34) . In the second model, H4B acts as an allosteric effector to maintain the enzyme in an active form. Either of these models or a combination of them may be invoked. Our further finding that H2B has a small but reproducible activity appears to be more compatible with the allosteric model. The small but significant MTX-insensitive stimulation by H2B (Tables 1 and 3) , coupled with the finding that H2B is not recycled to H4B, suggests that H2B per se is capable of stimulating NOS. There is only a small likelihood that H2B is acting as a reductant of NOS. Whereas 7,8-dihydropterins can reduce ferric iron, the rate of this reaction at pH 6.4 is at least 3 orders of magnitude less than the corresponding rate with tetrahydropterins (35) . Further, H2B typically acts as a biochemical oxidant (in the reaction catalyzed by DHFR), and no biological reaction is known in which H2B acts as a reductant. The finding that the combined effect of H2B and (6R)-H4B is intermediate between that of either alone (Table 3) is also consistent with an allosteric model in which the two pterins compete for the same binding site.
The present evidence that H4B is not a stoichiometric reductant in the transformation of arginine to nitric oxide and citrulline is not in accord with recent formulations that H4B is a stoichiometric reductant and is regenerated in the NOS system (7, 12, 13) . Stuehr et al. (13) , for example, have implied that in the conversion of hydroxyarginine, the intermediate in the reaction, to the products, not only is 0.5 mol of NADPH oxidized per mol of citrulline formed, but also H4B is stoichiometrically oxidized. An analysis of the net electron change involved in this reaction, however, indicates that there is no need to invoke any oxidation of H4B. Therefore, none of the published data (7, 12, 13) are incompatible with either our results or our conclusion.
